Elevated levels of granulocyte colony-stimulating factor (G-CSF) were detected in sera of these mice and also in the culture supernatants of Tax1-expressing human cells, suggesting that G-CSF in the mouse sera was produced by the human cells. In sera of some mice with splenomegaly and neutrophilia, high levels of murine granulocyte-macrophage colony-stimulating factor (mGM-CSF) were observed, suggesting that Tax1 produced by human cells induced mouse cells to produce mGM-CSF. Only S+L−HOS cell lines expressing Tax1 showed high tumorigenicity in nude mice. Thus, this system will be a useful model of tumor formation, splenomegaly and neutrophilia dependent on Tax1.
Introduction
Human T cell leukemia/lymphoma virus type I (HTLV-I) is the etiologic agent of adult T cell leukemia (ATL) 1 and HTLV-Iassociated myelopathy/tropical spastic paraparesis (HAM/ TSP). 2 This virus has a potential to transform normal human or animal T cells in vitro, 3, 4 but it has not yet been reported whether or how HTLV-I affects the tumorigenicity of the infected human or animal cells.
Tax1, a protein encoded by the pX region of the HTLV-I genome, 5 is a transcriptional trans-activator of this virus. 6 Tax1 activates not only the transcription from its own long terminal repeat (LTR), but also the transcription of many cellular genes. The immediate-early genes and oncogenes, eg c-fos, c-jun, egr-1, c-myc and c-sis, [7] [8] [9] [10] [11] cytokine genes, eg IFN-␣, IFN-␤, IL-1, IL-2, GM-CSF, etc [12] [13] [14] [15] and the IL-2 receptor gene (IL-2R), 16 have been reported to be transactivated in HTLV-I-infected or Tax1-expressing cell lines. In ATL or HAM/TSP patients, the elevated serum levels of cytokines such as IL-1, IL-6, GM-CSF, IFN-␥, TGF-␤, TNF-␣ and TNF-␤ etc and the activated production of some of these cytokines from leukemic cell or peripheral blood mononuclear cells have been reported. [17] [18] [19] [20] [21] [22] However, the production of these cytokines has not always been upregulated in ATL patients, HAM/TSP patients or HTLV-I carriers.
As an animal model for investigation of the tumorigenicity of HTLV-I, SCID mice injected with ATL cells or an HTLV-Itransformed T cell line were reported to form tumors. [23] [24] [25] A rat fibroblast cell line, transfected with pX or tax1 gene of HTLV-I, forms tumors when transplanted into nude mice. 26 In contrast, primary rat fibroblasts require both Tax1 and Ras to form tumors in nude mice, 27 indicating that Tax1 does not have a fully transforming activity. It has also been reported that neurofibromas, breast cancers, or large granular lymphocyte (LGL) leukemia with neutrophilia developed in a part of Tax1-transgenic mice or rats. [28] [29] [30] These reports indicate that Tax1 has a potentially tumor-inducing activity. However, in most reports, the effects of Tax1 have been examined under the control of promoters other than HTLV-I LTR, and none of these systems use cells harboring the complete HTLV-I genome. Thus, the role or contribution of HTLV-I in the tumorigenicity remains to be elucidated experimentally. For this analysis, the establishment of cell line pairs infected and uninfected with HTLV-I is necessary.
In this study, we transplanted HOS cells and HTLV-I-or Tax1-introduced HOS cells into nude mice. These HOS cells formed no tumors in nude mice. We also transplanted HTLV-I-or Tax1-positive HOS cells harboring M-MSV (S+L−HOS cells) or its oncogene v-mos into nude mice. Successful engraftments were observed after transplantation of these cells, and HTLV-I and Tax1 markedly enhanced tumor formation of S+L−HOS cells in mice. Marked splenomegaly and neutrophilia, which are typical signs of ATL, also developed in tumor-bearing mice. We examined how these changes were occurred in this model.
Materials and methods

Mice
Female athymic nude mice (BALB/c nu/nu), 7 weeks of age, were obtained from Nihon Clea Inc (Tokyo, Japan). The mice were maintained under specific pathogen-free conditions.
Plasmid construction
The pMo-MSV plasmid, 31 containing the Moloney murine sarcoma virus (M-MSV) genome, was obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). The v-mos encoding sequence was excised from pMo-MSV with XbaI and HindIII, and ligated to the HindIII sites of the pcDNA3 plasmid (InVitrogen, San Diego, CA, USA) to make pcDNA3-v-mos. The p21x5-Luc plasmid was constructed as described previously. 32 Briefly, the NruI-HindIII fragment from pR?U3.21x5-CAT7 plasmid, which contains five copies of the Tax1-responsive 21 base pair repeat sequence, was inserted into the SmaI and HindIII sites of the luciferase reporter plasmid pGV-B2 (Toyo B-net, Tokyo, Japan). pLA, 33 the ␤-gal expression vector, was obtained from Dr Noguchi (Meiji Institute of Health Science).
Cell lines
The human osteosarcoma cell line HOS and its subline S+L−HOS 34 harboring M-MSV but not Moloney murine leukemia virus (S+L−) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HOS/HTLV-I and S+L−HOS/HTLV-I cells infected with Melanesian HTLV-I MEL5 produced by SI-5 cells were established as reported previously. 35 Tax1 of Japanese HTLV-I 2M 36 was introduced into HOS and S+L−HOS cell lines by infection of DGL-Tax1 pseudotype virus prepared as described previously. 37 These cell lines were designated HOS/Tax and S+L−HOS/Tax. HOS/HTLV-I cells transfected with pcDNA3-v-mos were HOS/HTLV-I/v-mos. These transduced cells were selected and maintained in DMEM supplemented with 500 g/ml of G418 (Sigma, St Louis, MO, USA). HUT102 human T cell line producing HTLV-I was maintained in RPMI 1640 medium supplemented with 10% FBS.
Western blotting
HOS-derived cell lines were lysed with 200 l of the sample buffer consisting of 2% sodium dodecyl sulfate, 62.5 mM TrisHCl (pH 6.8), 10% glycerol, 50 mM dithiothreitol, and 0.02% bromphenol blue, incubated at 100°C for 5 min and then sonicated for 10 s. As a positive control of Tax1 expression, HUT102 HTLV-I-producing cells were used. For Western blotting, 200 g of total cellular protein was electrophoresed through 12% polyacrylamide gels. Following transfer to PVDF Immobilon membranes (Millipore, Bedford, MA, USA), the membranes were incubated in PBS containing 5% nonfat milk, reacted with a mouse monoclonal antibody, TAXY-8, against HTLV-I Tax1 38 and incubated with horse radish peroxidase-conjugated anti-mouse antibody (Dako, Glostrup, Denmark). Tax1 protein on the membranes was detected using the enhanced chemiluminescence ECL kit (Amersham, Buckinghamshire, UK).
Luciferase assay
The trans-activating activity of Tax1 in the HOS-derived cell lines was determined by the luciferase assays using the p21x5-Luc plasmid. 32 The cells were seeded at 8 × 10 5 into 60 mm dishes in duplicate, and transfected with p21x5-Luc or pLA plasmid using LipofectAMINE reagent (GIBCO/BRL, Rockville, MD, USA) 1 day later. Then, they were harvested after cultivation for 48 h and incubated in 250 l of Pica Gene Cell Lysis Reagent LC␤ (Toyo B-net) for 15 min. The luciferase activities in the cell lysates were determined by an Autolumat LB953 luminometer (Berthold, Bad Wildbad, Germany) using the Pica Gene luminescence kit according to the protocol of the manufacturer. Relative light units (RLU) obtained were normalized using protein concentrations of the cell lysates and transfection efficiencies, and expressed as RLU/20 ng of protein/transfection efficiency (corrected RLU). Protein concentrations were determined with the BCA protein assay reagent (Pierce, Rockford, IL, USA). Transfection efficiency of the p21x5-Luc plasmid for each cell line was estimated as follows. That is, cells were seeded into dishes in duplicate and transfected with p21x5-Luc or pLA plasmid. Half of the dishes were used for detection of ␤-galactosidase positive cells to estimate the transfection efficiency.
Injection of human cell lines into nude mice
Cells (2 × 10 7 ) were subcutaneously injected into nude mice at 8 weeks of age. Tumor sizes (maximum and minimum diameters and height) were measured weekly. Blood samples were obtained from the tail weekly, and white blood cells in them were counted and their hemograms examined. The number of neutrophils was calculated using data of these assays.
Histopathology
Six weeks after injection, blood samples were collected from the heart. Tumors and spleens were excised and spleen weights measured. The excised samples were fixed with 10% neutrally buffered formalin and stained with hematoxylin and eosin (H-E). 
Colony formation assays for hematopoietic cells
Spleen cell suspension was passed through stainless sieves and pipetted well. The cells (5 × 10 4 ) were then cultured in Iscove's modified Dulbecco's medium (IMDM), containing 30% FBS, 1% bovine serum albumin, 1.2% methylcellulose, and the following amounts of hematopoietic factors: 10 ng/ml of recombinant human G-CSF (rhG-CSF), 20 ng/ml of recombinant human GM-CSF (rhGM-CSF) or 100 ng/ml of recombinant murine GM-CSF (rmGM-CSF) (kindly provided by Kirin Brewery, Tokyo, Japan). The conditioned medium of S+L−HOS/HTLV-I cells was also examined at a final concentration of 10%. Dishes were incubated at 37°C in a humidified atmosphere under 5% CO 2 . After incubation for 4 days, numbers of colonies were counted using an inverted microscope.
Cytokine assays
Mouse sera and supernatants of HOS-derived cell lines were assayed in duplicate for hG-CSF and mGM-CSF using the Quantikine human G-CSF Immunoassay kit (R&D Systems, Minneapolis, MN, USA) and the mouse GM-CSF ELISA kit (Endogen, Cambridge, MA, USA), respectively. The hG-CSF kit is indicated to cross-react with mouse G-CSF. Detectable levels were determined to be over 7.0 pg/ml for hG-CSF and over 5.0 pg/ml for mGM-CSF.
Statistical analysis
The difference in tumor sizes, spleen weights, and neutrophil counts among each group of mice was compared by the Mann-Whitney's U test. The correlation between neutrophil counts and spleen weights was calculated by Spearman's rank correlation procedures.
Results
Preparation of cell lines infected with HTLV-I or transduced with tax1
In order to examine the effects of HTLV-I on the growth of human cells in vivo, we had cocultivated many human cells with HTLV-I-producing T cells, but could not isolate productively infected cells from most human cell lines such as Molt-4, Jurkat, Raji, K562, U937, HeLa and U-251MG. HowLeukemia Table 1 Properties of HOS-and S+L−HOS-derived cells used in this study ever, a human osteosarcoma cell line, HOS, and its subline S+L−HOS could be infected with HTLV-I rather easily as reported. 39 We also transduced tax1 into HOS and S+L−HOS cells as described above. Properties of cells used in this study are summarized in Table 1 .
Cell line
Tax1 protein expression in cell lines
To determine if the Tax1 protein was actually expressed in tax1 gene-introduced cells or HTLV-I-infected cells, we performed Western blotting assays. A protein with an apparent molecular mass of 40 kDa was detected in lysates of HTLV-I-infected cell lines such as HOS/HTLV-I, HOS/HTLV-I/v-mos and S+L−HOS/HTLV-I when the anti-Tax1 monoclonal antibody TAXY-8 was used (Figure 1a ). Tax1 was, however, not detected in the cell lysate of S+L−HOS/Tax cells.
In order to detect a small amount of Tax1, and to determine the promoter-enhancing activity of Tax1 quantitatively, we performed luciferase assay using p21x5-Luc plasmid ( Figure  1b Time course of tumor formation and neutrophil counts after transplantation. HOS or S+L−HOS cells expressing HTLV-I or Tax1 were injected subcutaneously into each group of six nude mice. Tumor sizes and neutrophil counts were examined weekly. Mean values of tumor sizes after injection of HOS cell line and its derivatives (a) or S+L−HOS series of cell lines (b) are shown. Tumor sizes were calculated as described in Table 2 . Mean values of neutrophil counts after injection of the HOS series of cell lines (c) or S+L−HOS series of cell lines (d) were plotted. One ( †) and two ( ‡) mice died before autopsy because of tumor growth. Neutrophil counts of mice (four to six) that survived until autopsy were examined.
Table 3
Detection of G-CSF and mGM-CSF in sera of neutrophilic mice and in the culture supernatants of cell lines transplanted 
Tumor formation in nude mice transplanted with human cell lines
We subcutaneously injected the HOS cell line and three related sublines positive for HTLV-I or Tax1 into nude mice ( Table 2) . As reported by Jones et al, 34 HOS cells made no tumors in nude mice. HOS cell lines expressing HTLV-I or Tax1, ie HOS/Tax and HOS/HTLV-I, also induced no tumors 
Tax1 protein expression in tumor-derived cells
The expression of Tax1 in the cultured cells recovered from the tumors was examined. Western blotting showed that similar amounts of Tax1 protein were detected in the cells reco- 
Neutrophilia and splenomegaly in tumor-bearing mice
We examined weekly neutrophil counts of the mice injected with these cell lines. At the time of injection, there was little difference in WBC and neutrophil counts among all groups of mice. As tumors in mice transplanted with human cells expressing HTLV-I or Tax1 grew larger, their neutrophil counts gradually increased week by week (Figure 2c (Table 2 and Figure 3 ), indicating that HTLV-I or Tax1 was necessary for the induction of neutrophilia.
Interestingly, marked splenomegaly was also noticed in tumor-bearing, neutrophilic mice. The spleen weights of the mice injected with S+L−HOS/Tax and S+L−HOS/HTLV-I cells became especially large and were several fold greater than those of the control mice (Figure 3a) . The spleens of the mice transplanted with HOS/HTLV-I/v-mos cells were also heavier than those of the controls, but not significantly (P = 0.07). However, there was little difference in spleen weights between the mice bearing small tumors derived from S+L−HOS cells and the control mice.
There was a significant correlation between neutrophil counts and spleen weights (Figure 3b ). Because the spleen is a hematopoietic organ in the mouse, these findings suggest that the activated hematopoiesis in the mouse spleens could be a cause of the neutrophilia.
Activated hematopoiesis in splenomegalic and neutrophilic mice
To determine whether hematopoiesis is activated in mice showing splenomegaly and neutrophilia, their spleens were histologically examined. Compared with spleens of control mice ( Figure 4A and B) , marked expansion of hematopoietic spaces and atrophy of lymphoid follicles were observed in neutrophilic mice transplanted with HOS/HTLV-I/v-mos, S+L−HOS/Tax or S+L−HOS/HTLV-I cells ( Figure 4C ). In their hematopoietic spaces, a marked increase of myeloid cells and a relative decrease of erythroid cells were observed ( Figure  4D ). In contrast, spleens of mice transplanted with S+L−HOS cells and bearing small tumors did not show these pathological changes (data not shown). 
Colony formation assays
To further confirm the activated hematopoiesis in the neutrophilic mice, colony formation of their spleen cells in semisolid medium was examined. Colonies were neither formed in any dishes in the absence of cytokines nor in the presence of rhGM-CSF (20 ng/ml). In the presence of rmGM-CSF (100 ng/ml), the number of colonies derived from the spleen cells of the mice transplanted with S+L−HOS/Tax (mouse No. 4 in Table 3 ) and S+L−HOS/HTLV-I cells (mice Nos 4 and 5 in Table 3 ) increased four-to seven-fold, respectively. rhG-CSF (10 ng/ml), which is known to show a cross-reactivity between human and mouse, 40 also enhanced the colony formation, but its effect was weaker than that of rmGM-CSF (Figure 5a ). The conditioned media of S+L−HOS/HTLV-I cells facilitated colony formation to a similar or even greater extent to that of rhG-CSF. These results indicate that the precursor cells committed to granulocytes were increased in the large spleens of the tumor-bearing mice, and that a cytokine(s)-like hG-CSF was present in the conditioned media of S+L−HOS/HTLV-I cells. High concentrations of G-CSF were detected in their culture supernatants (Table 3) .
To compare hematopoietic abilities of mice with splenomegaly more quantitatively, we calculated the Hematopoietic Index, which reflects the total number of precursor cells in the spleen of a mouse, as follows: mean colony number formed in the presence of mGM-CSF was multiplied by spleen weight (g) (Figure 5b ). These indices of the mice injected with S+L−HOS/Tax and S+L−HOS/HTLV-I cells were 10-to 20-fold higher than those of the control, indicating that the neutrophilia resulted from the activated hematopoiesis in the spleen, and suggesting that production of some cytokines from the tumors may be a cause of hematopoiesis activation.
Infiltration of neutrophils into tumors of neutrophilic mice
Tumors formed in the mice were examined histopathologically. Tumor tissues mainly consisted of tumor cells, and contained many blood vessels. In the tumors of the neutrophilic mice, focal ( Figure 6A 
Elevated serum levels of G-CSF and mGM-CSF in neutrophilic mice
Among cytokines having chemotactic effects on neutrophils and stimulatory effects on myeloid hematopoiesis, G-CSF is known to show species cross-reactivity between human and mouse. 40 Thus, we measured G-CSF concentrations in sera of mice by ELISA . Because of immunological cross-reaction between species, the assay kit could not distinguish hG-CSF from murine G-CSF. In all mice showing neutrophilia, G-CSF levels in sera were higher than those of the controls or nonneutrophilic mice (Table 3) , while G-CSF was not detected (Ͻ7.0 pg/ml) in sera of any mice without neutrophilia. Two of three mice transplanted with HOS/HTLV-I/v-mos cells showed high concentrations of G-CSF in their sera as well as severe neutrophilia. In almost all mice transplanted with S+L−HOS/Tax or S+L−HOS/HTLV-I cells, production of G-CSF at concentrations of 100 to 700 pg/ml was detected. There were a few mice which showed neutrophilia, but the concen- trations of G-CSF in their sera, were not so high (10-60 pg/ml) ( Table 3 ), suggesting that a cytokine(s) other than G-CSF could also cause neutrophilia. However, no human cytokines other than G-CSF have been reported to stimulate myeloid hematopoiesis of the mouse. It is probable that another cytokine was produced by mouse cells. If so, Tax1 released from human cells should induce the cytokine production by mouse cells. Thus, we examined mGM-CSF concentrations in mouse sera by ELISA. In the two mice transplanted with S+L−HOS/Tax (mouse No. 4) or S+L−HOS/HTLV-I (mouse No. 5) cells, concentrations of mGM-CSF in their sera were elevated (Table 3) .
G-CSF production by cultured cell lines
To examine whether hG-CSF was potentially produced by tumors formed in neutrophilic mice, hG-CSF concentrations in the supernatants of cultured cell lines were examined (Table 3, Figure 7 ). HOS cells did not produce G-CSF (Ͻ7 pg/ml), and M-MSV or tax1 gene-introduced HOS cell lines produced little G-CSF. On the other hand, HOS/HTLV-I, S+L−HOS/HTLV-I and HOS/HTLV-I/v-mos cells released large amounts of G-CSF into the culture medium. These findings suggest that G-CSF produced by the tumor-forming cells Leukemia causes neutrophilia and indicate that infection of HTLV-I activates production of hG-CSF. G-CSF was not detected in the culture supernatants of S+L−HOS/Tax cells.
Discussion
HTLV-I has the potential to transform normal T cells in vitro, 3 and Tax1, a transcriptional trans-activator of this virus, is thought to be responsible for this process. 41 Nerenberg et al 28 reported the establishment of Tax1-transgenic mice: these mice developed neurofibroma, showed neutrophilia due to production of mGM-CSF, and produced unknown factors from tumors that stimulated B cell proliferation and IgM secretion. 42, 43 Grossman et al 29, 44 reported large granular lymphocyte (LGL) leukemia in transgenic mice expressing Tax1 under the control of granzyme B promoter and suggested that neutrophilia and splenomegaly in these mice are probably caused by production of mGM-CSF from LGL cells. As for transplantation of HTLV-I-infected cells, engraftments of PBL cells from ATL patients or HTLV-I-producing MT-2 cell line in SCID mice were reported. [23] [24] [25] However, the exact role of Tax1 and HTLV-I in tumor formation has not been elucidated. Established cell lines of rat or mouse fibroblasts transduced with Tax1 formed tumors in nude mice. 26 In contrast, HTLV-I or Tax1 could not transform primary rat embryo fibroblasts: cooperation of ras, and tax1 27 or c-myc 45 is necessary for transformation of these cells. HOS cells also required v-mos or M-MSV, and HTLV-I or Tax1 for tumor formation in nude mice (Table 2, Figure 2 ). That is, HTLV-I or Tax1 may play a role similar to some oncogenes such as c-myc play in tumor formation.
There has been no suitable model that can comparatively examine the tumorigenicities of three types of cells, ie HTLV-I-infected cells, Tax1-transduced cells and their control cells. In this study, we tried to develop such a model: that is, HOS, HOS/HTLV-I and HOS/Tax cells (Table 1) . HOS/HTLV-I and HOS/Tax cells, however, did not form tumors in nude mice like parental HOS cells (Table 2, Figure 2 ). S+L−HOS cells formed small tumors in two-thirds of nude mice (Table 2) as reported previously. 34 It is possible that Tax1 derived from different HTLV-I strains such as MEL5 and 2M shows different trans-activating activities. HTLV-I that infects HOS or S+L−HOS cells is the MEL5 Melanesian strain, while Tax1 expressed by the DGL-Tax vector is derived from the 2M Japanese strain. Between these two strains, there are 91.5% homology in the amino acid sequences of the whole Tax1 proteins, and 97% homology in the first 100 amino acids of Tax1, which contain most of the active sites, have been reported. 46 There is yet another possibility that some part of HTLV-I other than Tax1 may participate in tumorigenicity.
As summarized in Table 2 , almost all mice transplanted with HOS/HTLV-I/v-mos, S+L−HOS/Tax or S+L−HOS/HTLV-I cells produced large tumors and showed marked splenomegaly and neutrophilia. There was a significant correlation between the spleen weights of mice and their neutrophil counts of blood (Figure 3b ). Histopathologic examination of the spleens of the neutrophilic mice showed activated hematopoiesis in myeloid series ( Figure 4C and D) . Colony formation assays of the spleen cells indicated increase of progenitor cells committed to granulocytes (Figure 5 ), suggesting that neutrophilia was induced by the activated granulopoiesis especially in the spleen. Histopathological examination of the tumors in the neutrophilic mice revealed marked invasion of neutrophils ( Figure 6 ), suggesting that the tumor cells produce neutrophil-attractive cytokines. In ATL patients, splenomegaly and neutrophilia are typical signs of this disease: neutrophil counts significantly increase as compared to patients with acute lymphoblastic leukemia or non-Hodgkin's lymphoma, or those of normal persons. 47, 48 Splenomegaly, neutrophilia and neutrophil invasion into tumor tissues probably due to production of mGM-CSF from neurofibroma or LGL leukemia cells were reported in tax1-transgenic mice as described above. 42, 44 In contrast, we observed high levels of G-CSF in sera of mice with neutrophilia and splenomegaly (Table 3) , while G-CSF was not detected (Ͻ7 pg/ml) in mice with normal neutrophil counts. There seems to be no report on serum concentrations of G-CSF in ATL patients, or on production of G-CSF in Tax1-expressing cells in vitro, although Himes et al 49 reported that Tax1 enhanced transcription from G-CSF promoter in human embryonic lung fibroblast cells. The production of G-CSF in the culture supernatants of HTLV-Iinfected HOS and S+L−HOS cells was confirmed as shown in Figure 7 . S+L−HOS/Tax cells did not produce a detectable level of G-CSF in their culture supernatants, although mice transplanted with these cells showed neutrophilia, splenomegaly and high serum G-CSF. Little production of G-CSF from S+L−HOS/Tax cells may be due to poor expression of Tax1 in S+L−HOS/Tax cells as shown in Figure 1 . High concentrations of serum G-CSF in these mice bearing S+L−HOS/Tax cell tumors may be due to G-CSF production from tumor-forming S+L−HOS/Tax cells, because S+L−HOS/Tax/Nu cells abundantly expressed Tax1 in vitro, and because the high level expression of Tax1 was correlated with high G-CSF production (Figures 1 and 7) .
Because concentrations of serum G-CSF might not be high enough to induce neutrophilia in some neutrophilic mice (Table 3) , possible involvement of other cytokines in hypergranulopoiesis was examined. mGM-CSF was elevated in two neutrophilic mice transplanted with S+L−HOS/Tax or S+L−HOS/HTLV-I cells ( Table 3 ), suggesting that the activated hematopoiesis was mainly due to the production of mGM-CSF in these mice. We considered that Tax1 protein released from the human tumor cells probably stimulated mouse cells to produce murine cytokines such as mGM-CSF in these mice. The following findings may support this possibility: soluble Tax1 protein is detected in the culture supernatant of MT-4 cells, 50 and addition of Tax1 protein to culture induces production of cytokines like IL-1␤ and IL-6. 51, 52 In our system, the tumor cells harboring HTLV-I or Tax1 are not producers of mGM-CSF unlike previous reports. 42, 44 Although neutrophilia is frequently observed in ATL patients, GM-CSF production by leukemic cells has been detected in only limited cases.
HTLV-I and Tax1 promoted the tumor formation of HOS cells expressing v-mos gene in nude mice. In most tumorbearing mice, marked splenomegaly and neutrophilia were detected, which have also been observed in ATL patients. This was possibly mediated through the production of cytokines, G-CSF or GM-CSF, induced by Tax1 or soluble Tax1. This is the first report to show that HTLV-I or Tax1 induced G-CSF production in human cells, and that neutrophilia and splenomegaly developed in the nude mice after transplantation of these cells. In ATL patients, the expression of HTLV-I antigens is known to be suppressed in leukemic cells. 36, 53 We also showed that even tax1 RNA is expressed in a small fraction of leukemic cells in peripheral blood. 54 If Tax1 is necessary for the induction of splenomegaly or neutrophilia, it will not be supplied by leukemic cells. Our findings suggest that production of a cytokine by non-leukemic cells, which is stimulated by soluble Tax1 protein, can be a cause of neutrophilia. Because HTLV-I will infect many types of cells, it is possible that non-lymphoid cells may be productively infected with HTLV-I in vivo. Our model reproduces some of the clinical features typical of ATL in nude mice within several weeks. Our system would be a rapid and versatile model for analysis of the tumorigenicity of HTLV-I and Tax1 and for assay of Tax1 function in vivo.
